Stifel Keeps Buy Rating on Compass Therapeutics (CMPX)

Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the 10 Best Performing Penny Stocks So Far in 2025. On July 14, Stifel reiterated its “Buy” rating for Compass Therapeutics, Inc. (NASDAQ:CMPX) with a price target of $11. This decision came after investor meetings with the company’s management.

According to the research firm, the extended timeline for overall survival event accrual in the Phase 2/3 COMPANION-002 trial is a good thing. The trial is testing paclitaxel with or without tovecimig in patients with second-line biliary tract cancer.

Stifel Keeps Buy Rating on Compass Therapeutics (CMPX)

A biopharmacist holding a magnifying glass up against a microscope lens, studying a biological sample.

Compass Therapeutics, Inc. (NASDAQ:CMPX) now expects to share the topline data in the fourth quarter of 2025. This means patients will be followed up for more than 19 months on average. Stifel noted that this is important because in this disease, the overall survival of the control arm rarely goes beyond 6 months.

Besides the COMPANION-002 trial, Stiefl analysts believe upcoming data disclosures for two other compounds in the second half of 2025 could potentially prove to be important catalysts for Compass Therapeutics, Inc. (NASDAQ:CMPX). These include Phase 1 dose-escalation data for CTX-8371, a PD-1xPD-L1 bispecific antibody, and preclinical data for CTX-10726, a PD-1xVEGF-A bispecific antibody.

Compass Therapeutics, Inc. (NASDAQ:CMPX) is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics. The company focuses on the relationship between angiogenesis, the immune system, and tumor growth.

While we acknowledge the potential of CMPX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CMPX and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.